← Back to Blog
Diagnostic AccuracyStudy DesignMethods Critique

Before the Analyzer: Does Specimen Handling Match Diagnostic Test Use?

October 26, 2026 · Aqrab editorial team

A diagnostic study reports excellent accuracy from samples processed in a central laboratory. The proposed clinic will collect, transport, and test samples on a different schedule. Before importing the accuracy estimate, ask a question that comes before sensitivity and specificity: did the study test the specimen pathway that patients will actually experience?

The Test Starts Before Measurement

Specimen collection and handling are part of the test procedure, not merely logistics. STARD 2015 asks diagnostic studies to describe the preanalytical phase, including patient preparation and sample handling, so readers can judge whether the procedure is reproducible and applicable. FDA reporting guidance likewise asks for specimen type, collection, storage, handling, and counts discarded or omitted from analysis.

These reporting requirements do not imply that every handling difference changes accuracy. They tell us where a study-to-practice gap may hide. Its size and direction require evidence for the specific test and intended workflow.

The practical takeaway

Draw the specimen path in the study and in the intended clinic, from patient preparation to result. Mark every difference and ask whether performance was measured under those conditions.

A Hypothetical Path Comparison

Illustrative workflow only; no real test or effect size is implied.
StepAccuracy studyPlanned clinic
CollectionStaff follow a research protocolRoutine collection across shifts
Transport and storageDocumented central-lab scheduleVariable courier and holding times
Analysis setOnly usable specimens reportedEvery collected specimen needs a disposition

The table identifies questions, not a verdict. A method may be stable across these differences—or it may not. If the study excludes unusable specimens, the reported accuracy among analyzed samples also leaves the frequency and consequences of failed specimens unanswered.

Four Questions to Ask Before Reusing the Estimate

  1. Preparation and collection: What patient preparation, specimen type, collection device, and timing were required? Do these match intended use?
  2. Transport and storage: How long and under what conditions were samples held before analysis? Were those conditions documented for every study site?
  3. Missing specimens: How many collected specimens were discarded, failed testing, or were omitted, and why? Were their patient characteristics reported?
  4. Applicability: Was performance evaluated under the proposed clinic pathway? If not, what local or prospective evaluation would close the gap?

A sensitivity-and-specificity pair from analyzable specimens answers a narrower question than whether the whole testing pathway works for every eligible patient.

Where Aqrab Fits

Use Aqrab to organize a methods critique of the specimen path, exclusions, and intended-use mismatch. A critique can identify evidence to request; it cannot infer how an unstudied handling change affects a particular test.

Source Anchors

The STARD 2015 explanation and elaboration describes preanalytical procedures and the need for enough detail to assess applicability. The FDA diagnostic-test reporting guidance recommends documenting specimen collection, storage, handling, and omitted specimens. The comparison above is fictional and makes no test-specific performance claim.

Keep reading

Don't stop at one method.

Good methods judgment comes from contrast. Read the neighboring guides, see where the assumptions diverge, and avoid treating every observational problem like it needs the same hammer.

Browse full archive